Validation of the Efficacy of Air Purifiers in Indoor Environment and Allergic Symptoms in Allergic Rhinitis Patients

Recruiting N/A Interventional Study
Rhinitis Allergic
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
19 – 60
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
44 (estimated)
Sponsor
Yonsei University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study targets adult patients between the ages of 19 and 60 who were diagnosed with allergic rhinitis caused by indoor inhalation antigens. Patients with moderate to severe and persistent allergic rhinitis who continue to require medication such as antihistamines and nasal spray steroids for allergic rhinitis are the subjects of this study. Patients who participate in the study will install a…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * adults aged 19 to 60 * A person with moderate-severe persistent allergic rhinitis diagnosed by an allergy specialist or otolaryngologist and maintained without any change in treatment for more than one month * Total nasal symptom Score ≥ 8 * Patients with allergic rhinitis cau…
Contacts

Kyung Hee Park

+82-2-2228-1947

white182@yuhs.ac

CONTACT

Im Shin

+82-2-2228-5884

si1011@yuhs.ac

CONTACT